Marchex Inc. (NASDAQ:MCHX), a company specializing in AI-driven conversation intelligence, reported financial results for the fourth quarter and full year 2025 that fell short of analyst expectations, contributing to a negative market reaction in after-hours trading.
Earnings and Revenue Versus Estimates
The company's Q4 results missed consensus targets on both the top and bottom lines. Revenue for the quarter came in at $10.8 million, below the analyst estimate of $11.2 million. This also represents a decline from the $11.9 million reported in the same quarter last year.
On a profitability basis, the adjusted non-GAAP loss per share was $(0.04), which was wider than the estimated loss of $(0.0102). The GAAP net loss for the quarter was $2.3 million, or $(0.05) per diluted share.
Key Q4 2025 Financial Results vs. Estimates:
- Reported Revenue: $10.8 million
- Analyst Estimate for Revenue: $11.2 million
- Reported Adj. Non-GAAP EPS: $(0.04)
- Analyst Estimate for EPS: $(0.0102)
For the full year 2025, GAAP revenue was $45.4 million, down from $48.1 million in 2024. The company's net loss for the year widened slightly to $5.2 million from $4.9 million in the prior year.
Market Reaction and Price Action
Following the earnings release, shares of Marchex traded lower in the after-market session. This immediate negative price action appears to be a direct response to the earnings and revenue misses, coupled with a year-over-year decline in sales. The market is signaling disappointment with the company's recent financial performance against expectations.
Strategic Outlook and Forward Guidance
Management attributed the quarterly revenue pressure to a significant technology platform migration completed in December, which involved moving approximately 1,000 customers and resulted in some "revenue dilution." President Troy Hartless stated that with this transition now behind them, the company is positioned to focus on accelerating revenue growth and margin expansion in 2026.
The press release provided specific forward-looking commentary. For the first quarter of 2026, Marchex anticipates revenue to be in the range of Q4 2025 levels (approximately $10.8 million) and expects Adjusted EBITDA to be $500,000 or more. This revenue projection is notably below the current analyst consensus estimate of $11.6 million for Q1 2026.
The company's outlook becomes more optimistic for the latter half of the year. Marchex anticipates sequential quarterly revenue increases during 2026, aiming for a run-rate growth of approximately 10% from year-end 2025 levels. It also projects Adjusted EBITDA margins reaching 10% or more during the year.
The Archenia Transaction
A major focal point of the announcement was an update on the proposed acquisition of Archenia, Inc., a performance-based customer acquisition company. The deal, announced in November 2025, is pending definitive agreements, audited financials, a fairness opinion, and stockholder approval, with an anticipated closing in June 2026.
Management believes the combination would create a vertically focused, AI-driven platform with an expanded addressable market. They estimate the combined company's current revenue run rate is approximately $60 million annualized, with the potential to grow 15-20% in 2026. Archenia itself estimates its 2025 revenue was over $17 million with positive Adjusted EBITDA.
Press Release Summary
The key takeaways from Marchex's announcement are:
- Q4 and full-year 2025 financial results missed analyst estimates.
- Management cites a completed platform migration as a near-term headwind to revenue.
- The company provided detailed financial guidance for 2026, initiating a Q1 revenue outlook below analyst expectations but forecasting sequential growth and margin expansion later in the year.
- The pending acquisition of Archenia is framed as a central growth catalyst, potentially significantly scaling the business.
For a detailed look at Marchex's historical earnings and future analyst projections, you can review the earnings history and analyst estimates & forecasts.
Disclaimer: This article is for informational purposes only and does not constitute financial advice, nor a recommendation to buy or sell any security. Investors should conduct their own research and consult with a qualified financial advisor before making any investment decisions.